Amarantus Subsidiary MANF Therapeutics Announces Positive Independent Peer-Reviewed Pre-Clinical Data for MANF in Parkinson's Disease
Biospace,
Data show in-animal increases in free-release dopamine and dopamine turnover SAN FRANCISCO, Jan.
Data show in-animal increases in free-release dopamine and dopamine turnover SAN FRANCISCO, Jan.
SAN FRANCISCO, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc.
GlobeNewswire 2018-01-29 Data show in-animal increases in free-release dopamine and dopamine turnover SAN FRANCISCO, Jan.
SAN FRANCISCO, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- The published data show that 1 week after MANF treatment…